Efficacy and safety of fluocinolone acetonide intravitreal implant (0.2 µg/day) in patients with post-surgical inflammation associated with macular edema: a case series study
The FAc implant significantly improved both visual and anatomic outcomes, and was effective in preventing recurrences, while maintaining a reasonable safety profile, in PCME refractory to intravitreal triancinolone and dexamethasone.
Authors
- Marta Guedes (ORCID: https://orcid.org/0000-0001-5442-5571)
- Ana Cabugueira
- Helena Urbano
- Miguel Cordeiro (ORCID: https://orcid.org/0000-0003-4656-6045)
- Maria Madeira (ORCID: https://orcid.org/0009-0009-2756-9145)
Institutions
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-08-16
- DOI
- https://doi.org/10.1186/s12348-025-00503-8
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alimera Sciences